The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Growth in premature infants (percentile ranking at 36 weeks CGA)
研究概览
简要总结
The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- — 至 40 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Infants less than 2000 gms at birth, receiving maternal breast milk
排除标准
- •Infants receiving formula
研究组 & 干预措施
control
infants in this arm will receive the current treatment that is standard of care for these infants, powder protein modular to achieve 4 gm/kg/day
干预措施: Powder protein modular (Dietary Supplement)
experimental
this group will receive a liquid protein modular that recently became commercially avaliable, to achieve the same protein of 4 grm/kg/day as the powder comparision group
干预措施: Liquid protein modular (Dietary Supplement)
结局指标
主要结局
Growth in premature infants (percentile ranking at 36 weeks CGA)
时间窗: birth to 36 weeks
次要结局
- GI tolerance(birth to 36 weeks)
研究者
Corrine K. Hanson, PhD
IRB Administrator
University of Nebraska